Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD

被引:30
|
作者
Sun, D-Q [1 ,2 ]
Ye, F-Z [3 ,4 ]
Kani, H. T. [5 ]
Yang, J-R [6 ]
Zheng, K., I [3 ]
Zhang, H-Y [7 ]
Targher, G. [8 ,9 ]
Byrne, C. D. [10 ]
Chen, Y-P [3 ,11 ,13 ]
Yuan, W-J [2 ]
Yilmaz, Y. [5 ,12 ]
Zheng, M-H [3 ,11 ]
机构
[1] Nanjing Med Univ, Affiliated Wuxi 2 Peoples Hosp, Dept Nephrol, Wuxi, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Shanghai Gen Hosp, Dept Nephrol, Shanghai, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, NAFLD Res Ctr, Dept Hepatol, 2 Fuxue Lane, Wenzhou 325000, Peoples R China
[4] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou, Peoples R China
[5] Marmara Univ, Sch Med, Dept Gastroenterol, TR-34662 Istanbul, Turkey
[6] Wenzhou Med Univ, Affiliated Hosp 1, Dept Clin Lab, Wenzhou, Peoples R China
[7] Sun Yat Sen Univ, Sch Biomed Engn, Guangzhou, Peoples R China
[8] Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, Verona, Italy
[9] Azienda Osped Univ Integrata Verona, Verona, Italy
[10] Univ Hosp Southampton, Southampton Gen Hosp, Southampton Natl Inst Hlth Res, Biomed Res Ctr, Southampton, Hants, England
[11] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[12] Marmara Univ, Inst Gastroenterol, Istanbul, Turkey
[13] Key Lab Diag & Treatment Dev Chron Liver Dis Zhej, Wenzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Early kidney dysfunction; Liver fibrosis; Liver stiffness measurement; Non-alcoholic fatty liver disease; INSULIN-RESISTANCE; DISEASE; RISK; MICROALBUMINURIA; STEATOHEPATITIS; STRESS;
D O I
10.1016/j.diabet.2019.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. - The association between Liver fibrosis (LF), as assessed by either histology or Liver stiffness measurement (LSM), and the presence of Early kidney dysfunction (EKD) was investigated in this study, as was also the diagnostic performance of LSM for identifying the presence of EKD in patients with Nonalcoholic fatty liver disease (NAFLD). Materials and methods. - A total of 214 adults with non-cirrhotic biopsy-proven NAFLD were recruited from two independent medical centres. Their histological stage of LF was quantified using Brunt's criteria. Vibration-controlled Transient elastography (TE), using M-p robe ( Fib roScan (R)) ultrasound, was performed in 154 patients and defined as significant when LSM was >= 8.0 kPa. EKD was defined as the presence of microalbuminuria with an estimated glomerular filtration rate >= 60 mL/min/1.73 m(2). Logistic regression modelling was used to estimate the likelihood of having EKD with NAFLD (LSM-EKD model). Results. - The prevalence of EKD was higher in patients with vs without LF on histology (22.14% vs 4.82%, respectively; P < 0.001) and, similarly, EKD prevalence was higher in patients with LSM >= 8.0 kPa vs LSM < 8.0 kPa (23.81% vs 6.59%, respectively; P < 0.05). The area under the ROC curve of the LSM-EKD model for identifying EKD was 0.80 (95% CI: 0.72-0.89). LF detected by either method was associated with EKD independently of established renal risk factors and potential confounders. Conclusion. - LF was independently associated with EKD in patients with biopsy-proven NAFLD. Thus, TE-measured LSM, a widely used technique for quantifying LF, can accurately identify those patients with NAFLD who are at risk of having EKD. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:288 / 295
页数:8
相关论文
共 50 条
  • [31] PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) WITHOUT ASSOCIATED ETIOLOGIES AND NON-MAFLD NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) HAVE SIMILAR LIVER DISEASE SEVERITY --DATA FROM INDIAN CONSORTIUM ON NAFLD (ICON-D).
    Duseja, Ajay K.
    De, Arka
    Mehta, Manu
    Singh, Shivaram P.
    Mukewar, Shrikant
    Mukewar, Saurabh
    Goyal, Omesh
    Shalimar
    Venkataraman, Jayanthi
    Devadas, Krishnadas
    Mehta, Varun
    Kar, Sanjib
    Nagral, Aabha
    Choudhary, Narendra S.
    Ranjan, Piyush
    Arora, Anil
    Nijhawan, Sandeep
    Praharaj, Dibyalochan
    Shukla, Akash
    Rao, Padaki Nagaraja
    Sharma, Brij
    Narayanasamy, K.
    Mehta, Rajiv M.
    Asati, Pankaj
    Prasad, V. G. Mohan
    Rastogi, Mukul
    Dadhich, Sunil
    Saigal, Sanjiv
    Koshy, Abraham
    Alam, Seema
    Madan, Kaushal
    Mohan, Neelam
    Pandey, Gaurav
    Lal, Sadhna B.
    Jothimani, Dinesh K.
    Wadhawan, Manav
    Agarwal, Swastik
    Shah, Samir
    Valsan, Arun
    Chandail, Vijant
    Shenoy, Thrivikrama
    Gupta, Rohit
    Choudhari, Gaurdas
    Kalal, Chetan Ramesh
    Bhattacharyya, Mallika
    Sharma, Manoj K.
    Tevethia, Harsh Vardhan
    Dixit, Vinod
    Sanyal, Arun J.
    HEPATOLOGY, 2022, 76 : S811 - S812
  • [32] Non-Invasive Liver Fibrosis Scores Are Associated With Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention
    He, Hao-Ming
    He, Chen
    You, Zhe-Bin
    Zhang, Si-Cheng
    Lin, Xue-Qin
    Luo, Man-Qing
    Lin, Mao-Qing
    Zhang, Li-Wei
    Lin, Kai-Yang
    Guo, Yan-Song
    ANGIOLOGY, 2023, 74 (04) : 333 - 343
  • [33] COMPARATIVE DIAGNOSTIC ACCURACY OF AGILE SCORES AND COMMON NON-INVASIVE TESTS IN DETECTING ADVANCED LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
    Ismail, Mona
    Kuriry, Hadi
    Ismail, Marwa
    HEPATOLOGY, 2024, 80 : S665 - S666
  • [34] Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients
    Dabbah, Shoham
    Ben Yakov, Gil
    Kaufmann, Monika-Inda
    Cohen-Ezra, Oranit
    Likhter, Maria
    Davidov, Yana
    Ben Ari, Ziv
    MINERVA GASTROENTEROLOGY, 2024, 70 (03): : 322 - 331
  • [35] LOWER HUMAN ACTIVITY PROFILES ARE ASSOCIATED WITH HIGHER FATIGUE SCORE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND HEPATITIS C VIRUS (HCV)
    Karrar, Azza K.
    VanderNoot, Natalie
    Price, Jillian Kaltman
    Austin, Patrick W.
    Escheik, Carey
    De Avila, Leyla
    Weinstein, Ali A.
    Gerber, Lynn
    Younossi, Zobair M.
    HEPATOLOGY, 2020, 72 : 981 - 981
  • [36] Early aminotransferase improvement in the phase 2b NATIVE study is predictive of response pattern of liver histology as well as hepatic and cardiometabolic health markers at the end of treatment in patients with non-cirrhotic NASH
    Anstee, Quentin
    Huot-Marchand, Philippe
    Dzen, Lucile
    Junien, Jean-Louis
    Broqua, Pierre
    Francque, Sven
    Abdelmalek, Manal
    Cooreman, Michael
    Harrison, Stephen
    JOURNAL OF HEPATOLOGY, 2023, 78 : S651 - S651
  • [37] FACTORS ASSOCIATED WITH HIGH ACTIVITY AND FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES POPULATION: THE ROLE OF ASSESSMENT BY FIBROSCAN-AST (FAST) SCORES
    Paik, James M.
    Felix, Sean
    Younossi, Elena
    Lam, Brian P.
    Henry, Linda
    Younossi, Zobair M.
    HEPATOLOGY, 2022, 76 : S709 - S710
  • [38] Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores
    Capela, Tiago Lima
    Silva, Vitor Macedo
    Freitas, Marta
    Arieira, Catia
    Goncalves, Tiago Curdia
    de Castro, Francisca Dias
    Magalhaes, Joana
    Cotter, Jose
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [39] Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores
    Tiago Lima Capela
    Vítor Macedo Silva
    Marta Freitas
    Cátia Arieira
    Tiago Cúrdia Gonçalves
    Francisca Dias de Castro
    Joana Magalhães
    José Cotter
    BMC Gastroenterology, 23
  • [40] INSULIN RESISTANCE AND LIVER DAMAGE ARE ASSOCIATED WITH EARLY SIGNS OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN NON-DIABETIC, NON-DYSLIPIDEMIC, NORMOTENSIVE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Vanni, E.
    Mezzabotta, L.
    Faletti, R.
    Morello, M.
    Marengo, A.
    Battisti, G.
    Frea, S.
    Cannillo, M.
    Rosso, C.
    Mosso, E.
    Bergamasco, L.
    Rizzetto, M.
    Bugianesi, E.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E20 - E20